课题基金基金详情
lncUTPF的m6A甲基化及其通过其宿主基因Picalm和靶标蛋白hnRNP A2B1/C1C2-端粒信号通路调控肺纤维化发生的机制
结题报告
批准号:
81970064
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
宋晓冬
依托单位:
学科分类:
间质性肺疾病
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
宋晓冬
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
项目组多年来以长链非编码RNA(lncRNA)为研究特发性肺纤维化(IPF)发生机制的切入点,发现一条上调表达极显著的RNA转录本,命名为lncUTPF。体外翻译等实验证明其不具备编码能力,由其宿主基因Picalm的互补链转录而来,受到m6A甲基化修饰的影响。同时RNA-FISH等实验显示lncUTPF在胞核和胞质中均有分布,能与hnRNP A2B1/C1C2结合,形成RNA-蛋白复合物,调控端粒信号通路。. 该项目拟构建lncUTPF功能获得和缺失成纤维细胞和小鼠肺纤维化模型,研究lncUTPF的m6A甲基化修饰及在细胞质与细胞核中分别通过其宿主基因Picalm和hnRNP A2B1/C1C2-端粒信号通路调控肺纤维化发生的机制,揭示一个由非编码基因介导的遗传信息传递方式,为lncUTPF的临床应用和鉴定新的药物和基因治疗靶点提供思路和方案。
英文摘要
Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic and progressive interstitial pneumonia of an unknown cause, and this disease leads to the progressive loss of lung function, respiratory failure, and death. To date, lung transplant is the only effective treatment available for IPF. Thus, a comprehensive understanding of the molecular mechanisms of fibrogenesis is required in developing specific therapies toward this disease.. The majority of genomes are transcribed using modern molecular biology techniques, such as deep sequencing; however, only 3% of the transcribed genome codes are attributed to proteins. The remaining part of the transcribed genome is known as noncoding RNA (ncRNA). ncRNAs can be divided into miRNA, long noncoding RNAs (lncRNA), ribosomal RNA and so on. Although lncRNA plays important roles in the development and progression of diseases, the mechanism of lncRNA in IPF remains unknown. This project is a follow-up to a previously completed research in our laboratory. In the present project, we defined a novel lncUTPF, its m6A methylation, and the crosstalk among its host gene Picalm and target protein hnRNP A2B1/C1C2-telomere signaling pathway in the regulation of fibrogenesis. . Over the years, our team has used long non-coding RNA (lncRNA) as the entry point for the study of the mechanism of IPF, and found an RNA transcript NONMMUT062668.2 with an extremely significant up-regulated expression. The transcript lacks the ability to encode a protein and is unreported lncRNA that is transcribed by the complementary strand of its host gene Picalm. M6A methylation effects its changes through methylation experiments. RNA pull down, mass spectrometry and other experimental results show that NONMMUT062668.2 can bind to hnRNP A2B1/C1C2 proteins to form RNA-protein complexes, bind to telomere single-stranded DNA, telomerase RNA, and holoenzymes to maintain telomerase activity and telomere length. So we named it lncUTPF (upregulated lncRNA associated with telomere in pulmonary fibrosis). . This project intends to use fibroblast model constructed by genome editing technology, mouse pulmonary fibrosis model and IPF patient specimen. What is the mechanism of lncUTPF m6A methylation and its regulatory host gene Picalm? How does it modulate the physiological and pathological states of telomeres by combining hnRNP A2B1/C1C2, leading to the occurrence of pulmonary fibrosis? Can it be used as a blood biomarker during the progress of pulmonary fibrosis? . All in all, our team try to reveal a genetic information transmission and regulatory network mediated by long non-coding genes, annotate and elucidate the structure and function of the genome from the perspective of protein coding genes, and provide candidate genes for IPF gene therapy or drug targets.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1080/15548627.2022.2046448
发表时间:2022-11
期刊:AUTOPHAGY
影响因子:13.3
作者:Zhang, Jinjin;Wang, Haixia;Chen, Hongbin;Li, Hongbo;Xu, Pan;Liu, Bo;Zhang, Qian;Lv, Changjun;Song, Xiaodong
通讯作者:Song, Xiaodong
DOI:10.3389/fphar.2022.1013098
发表时间:2022
期刊:Frontiers in pharmacology
影响因子:5.6
作者:
通讯作者:
Astaxanthin attenuates pulmonary fibrosis through lncITPF and mitochondria-mediated signal pathways.
虾青素通过 lncITPF 和线粒体介导的信号通路减轻肺纤维化
DOI:10.1111/jcmm.15477
发表时间:2020-09
期刊:Journal of cellular and molecular medicine
影响因子:5.3
作者:Chen H;Wang J;Li R;Lv C;Xu P;Wang Y;Song X;Zhang J
通讯作者:Zhang J
DOI:10.1016/j.ymthe.2022.01.045
发表时间:2022-06-01
期刊:MOLECULAR THERAPY
影响因子:12.4
作者:Xu, Pan;Zhang, Jinjin;Wang, Meirong;Liu, Bo;Li, Rongrong;Li, Hongbo;Zhai, Nailiang;Liu, Weili;Lv, Changjun;Song, Xiaodong
通讯作者:Song, Xiaodong
Senescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment.
衰老AECⅨ及其对特发性肺纤维化治疗的意义
DOI:10.3389/fphar.2022.1059434
发表时间:2022
期刊:Frontiers in pharmacology
影响因子:5.6
作者:
通讯作者:
肺纤维化发生中circELP2靶向TRIM25–14-3-3ζ–YAP通路介导超级增强子的形成促进细胞骨架重构的机制
  • 批准号:
    82370094
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    宋晓冬
  • 依托单位:
乙酰氧苯甲酸黄杞苷酯的合成及其抗肺纤维化作用中对lncRNA的调控机制研究
  • 批准号:
    31670365
  • 项目类别:
    面上项目
  • 资助金额:
    61.0万元
  • 批准年份:
    2016
  • 负责人:
    宋晓冬
  • 依托单位:
国内基金
海外基金